In his latest research note, analyst Charles Eden confirms his positive recommendation. The broker UBS is keeping its Buy rating. The target price has been raised from EUR 120 to EUR 131.
In a research note published by Charles Eden, UBS advises its customers to Sell the stock. The target price is being increased from CHF 2860 to CHF 2950.